- Trousseau A. Anonymous Clinique Medicale de 1'Hotel-Dieu de Paris, 2nd: Glycosurie, diabete sucre. Paris: Balliere, 1865; 663.
- von Recklinghausen FD. Taggeblet der (62) Versainumlung Deutsch Naturforscher und Arzte in Heidelberg. 1889; 324-5.
- Sheldon JH. Haemochromatosis. London: Oxford University Press, 1935; 382
- Bassett ML, Halliday JW, Powell LW. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 1986; 6(1): 24-9.
- Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with haemochromatosis. J Pathol Bacterial 1962; 84: 53-64.
- Feder JN, Gnirke A, Thomas W, et al. A novel MHC class -I like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996; 13: 399-408.
- Powell LW, Leggett BA, Crawford DHG, et al., editors. Hemochromatosis and other iron storage disorders. In, Schiff's Diseases of the Liver, Eighth Edition. Philadelphia: Lippincott-Raven, 1998; in press.
- Milman N. Hereditary haemochromatosis in Denmark 1950-1985: clinical, biochemical and histological features in 179 patients and 13 preclinical cases. Dan Mod Bull 1991; 38: 385-93.
- Adams PC, Deugnier Y, Moirand R, Brissot P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology 1997; 25: 162-6.
- Lamon JM, Marynick SP, Roseblatt R, Donnelly S. Idiopathic hemochroamtosis in a young female. A case study and review of the syndrome in young people. Gastroenterology 1979; 76: 178-83.
- Felts JH, Nelson JR, Herndon CN, Spurr CL. Hemochromatosis in two young sisters. Case studies and a family survey. Ann Intern Med 1967; 67: 117-23.
- Charlton RW, Abrahams C, Bothwell TH. Idiopathic hemochromatosis in young subjects. Clinical, pathological, and chemical findings in four patients. Arch Pathol 1967; 83: 132-40.
- Cazzola M, Ascari E, Claudiani G, et al. Juvenile idiopathic haemochromatosis: a life-threatening disorder presenting as hypogonadotropic hypogonadism. Hum Genet 1983; 65: 149-54.
- Camaschella C, Cicilano M, Bosio S, et al. Juvenile and adult hemochromatosis are distinct genetic disorders. Eur J Hum Genet 1997; 5: 371-5.
- Knisely AS, Magid MS, Dische MR, Cutz E. Neonatal hemochromatosis. Birth Defects 1987; 23: 75-102.
- Witzelbin CL, Uri A. Perinatal hemochromatosis: entity or end result? Hum Pathol 1989; 20 335-40.
- Silver MM, Beverley DW, Valberg LS, et al. Perinatal hemochromatosis: clinical morphologic and quantitative iron studies. Am J Pathol 1987; 128: 538-54.
- Verloes A, Temple IK, Hubert A, et al. Recurrence of neonatal haemochromatosis in half sibs born of unaffected mothers. J Med Genet 1996; 33: 444-9.
- Rand EB, McClenathan DT, Whitington PF. Neonatal hemochromatosis: report of successful orthotopic liver transplantation. J Pediatr Gasroenterol Nutr 1992; 15: 325-9.
- Knisely AS. Neonatal hemochromatosis. Adv Pediatr 1992; 39: 383-403.
- MacDonald RA. Hemochromatosis and hemosiderosis. (Springfield, IL: Charles C. Thomas, 1964.
- Simon M, Bourel M, Fauchet R, Genetet B. Association of HLA A3 and HLA B14 antigens with idiopathic hemochromatosis. Gut 1976; 17: 332-4.
- Walters JM, Watt DW, Stevens FM, McCarthy CF. HLA antigens in haemochromatosis. Br Med J 1975; 4: 520.
- Simon M, Alexandre JL, Bourel M, et al. Heredity of idiopathic hemochromatosis: a study of 106 families. Clin Genet 1977; 11: 327-41.
- Doran T, Bashir HV, Trejaut J, et al. Idiopathic hemochromatosis in the Australian population: HLA linkage and recessivity. Hum lmmunol 1981; 2: 191-200.
- Ritter B, Safwenberg J, Olsson KS. HLA as a marker of the hemochromatosis gene in Sweden. Hum Genet 1984; 68: 62-6.
- Summers KM, Tarn KS, Halliday JW, Powell LW. HLA determinants in an Australian population of hemochromatosis patients and their families. Am J Hum Genet 1989; 45: 41-8.
- Santas M, Schilham MW, Rademakers LPHM, et al. Defective iron homeostasis in ß2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. / Exp Med 1996; 184: 1975-85.
- Rothenberg BE, Voland JR. Beta-2-microglobulin knockout mice develop parenchyma! iron overload: a putative role for class I genes of the major histocompatibility complex in iron metabolism. Proc Natl Acad Sei USA 1996; 93: 1529-34.
- Carella M, D'Ambrosio L, Totaro A, et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet 1997; 60: 828-82.
- Jazwinska EC, Cullen LM, Busfield F, etal. Haemochromatosis and HLA-H [letter]. Nat Genet 1996; 14: 249-51.
- Jouanolle AM, Gandon G, Jezequel P, et al. Haemochromatosis and HLA-H. Nat Genet 1996; 14: 251-2.
- Worwood M, Shearman JD, Wallace DF, et al. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997; 41: 841-4.
- Bacon BR, Powell LW, Adams PC, et al. Molecular medicine and hemochromatosis: at the crossroads. Gastroenterology 1999; 116: 193-207.
- Edwards CQ, Griffin LM, Goldgar D, et al. Prevalence of hemocmomatosis among 11,065 presumably healthy blood donors. New Engl J Med 1988; 318(1): 1355-62.
- Leggett BA, Halliday JW, Brown NN, et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990; 74: 525-30.
- Merryweather-Clarke AT, Pointon JJ, Shearman JD, Robson KJH. Global prevalence of putative haemochrornatosis mutations. J Med Genet 1997; 34: 275-8.
- Cullen LM, Summerville L, Glassick TV, et al. Neonatal screening for the haemochromatosis defect. Blood 1997; 90: 423-7.
- Roberts AG, Whatley SD, Morgan RR, et al. Increased frequency of the haemochromatosis Cys282Tyr mutation in sporadic porphyria cutanea tarda. Lancet 1997; 349: 321-3.
- Sampietro M, Piperno A, Lupica L, et al. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria curtanea tarda. Hepatology 1998; 27: 181-4.
- Stuart KA, Busfield F, Jazwinska EC, et al. The C282Y mutation in haemochromatosis (HFE) gene and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients. J Hepatol 1998; 28: 404-9.
- George DK, Goldwurm S, Macdonald GA, et al. Increased hepatic iron stores on non alcoholic steatohepatitis are associated with the hemochromatosis mutation and increased liver damage. Gastroenterology 1998; 114: 311-8.
- Turlin B, Juguet F, Moirand R, et al. Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology 1995; 22: 446-50.
- Deugnier YM, Charalambous P, Le Quilleuc D, et al. Preneoplastic significance of hepatic iron-free foci in genetic hemochromatosis: a study of 185 patients. Hepatology 1993; 18: 1363-9.
- Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981; 1293-4.
- Lauffer RB. Iron stores and the international variation in mortality from coronary artery disease. Med Hypotheses 1990; 35: 96-102.
- Miller M, Hutchins GM. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease. J Am Med Assoc 1994; 272: 231-3.
- Smith BC, Grove J, Guzail MA, et al. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C. Hepatology 1998; 27: 1695-9.
- Barton JC, Harmon L, Rivers C, Acton RT. Hemochromatosis: association of severity of iron overload with genetic markers. Blood Cells Molecules Dis 1996; 22: 195-204.
- Crawford DH, Halliday JW, Summers KM, et al. Concordance of iron storage in siblings with genetic hemochromatosis: evidence for a predominantly genetic effect on iron storage. Hepatology 1993; 17: 833-7.
- Muir WA, McLaren GD, Braun W, Askari A. Evidence for heterogeneity in hereditary hemochromatosis. Evaluation of 174 persons in nine families. Am J Med 1984; 76: 806-14.
- Adams PC. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: an analysis of 255 heterozygotes. Am J Hematol 1994; 45: 146-9.
- Bulaj ZJ, Griffen BA, Jorde LB, et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. New Engl J Med 1996; 335: 1799-805.
- Borot N, Roth M, Malfroy L, et al. Mutations in the MHC class I-like candidate gene for hemochromatosis in French patients. Immunogenetics 1997; 45: 320-4.
- Sham RL, Ou CY, Cappuccio J, et al. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases. Blood Cells Molecules Dis 1997; 23: 314-20.
- Crawford DH, Powell LW, Leggett BA, et al. Evidence that the ancestral haplotype in Australian hemochromatosis patients may be associated with a common mutation in the gene. Am J Hum Genet 1995; 57: 362-7.
- Crawford DHG, Jazwinska EC, Cullen LM, Powell L.W. Expression of HLA-linked hemochromatosis in subjects homozygous or heterozygous subjects for the C282Y mutation. Gastroenterology 1998; 114: 1003-8.
- Cox TM, Peters T. Uptake of iron by duodenal biopsy specimens from patients with iron deficiency anaemia and primary haemochromatosis. Lancet 1978; 1: 123-4.
- Raja KB, Pountney D, Bomford A, et al. A duodenal mucosal abnormality in the reduction of Fe(III) in patients with genetic haemochromatosis. Gut 1996; 38: 765-9.
- Powell LW, Campbell CB, Wilson E. Intestinal mucosal uptake of iron and iron retention in idiopathic hemochromatosis as evidence of a mucosal abnormality. Gut 1970; 11: 727-31.
- Feder JN, Penny DM, Irrinki A, et al. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding. Proc Nat Acad Sci USA 1998; 1477.
- Fleming M, Trenor C, Su M, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997; 16: 383-6.
- Gunshin H, Mackenzie B, Berger U, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997; 388: 482-8.
- Hentze MW, Kuhn LC. Molecular control of vertebrate iron metabolism: mRNA-based regulatory circuits operated by iron, nitric-oxide, and oxidative stress. Proc Natl Acad Sei USA 1996; 93: 8175-82.
- Sciot R, Paterson AC, Van Den Ocrd JJ, Desmet VJ. Lack of hepatic transform receptor expression in hemochromatosis. Hepatology 1987; 7: 831-7.
- Lombard M, Bomford A, Hynes M, et al. Regulation of the hepatic transform receptor in hereditary hemochromatosis. Hepatology 1989; 9: 1-5.
- Pietrangelo A, Rocchi E, Rigo G, a al. Regulation of transferrin, transform receptor and ferritin gene expression in the duodenum of normal anemic and siderotic subjects. Gastroenterology 1992; 102: 802-9.
- Flanagan PR, Hajdu A, Adams PC. Iron-responsive element-binding protein in hemochromatosis liver and intestine. Hepatology 1995; 22: 828-32.
- Britton RS, Bacon BR, Recknagel RO. Lipid peroxidation and associated hepatic organelle dysfunction in iron overload. Chem Phys Lipids 1987; 45: 207-39.
- Tavill AS, Sharma BK, Bacon BR. Iron and the liver: genetic hemochromatosis and other hepatic iron overload disorders. Prog Liver Dis 1990; 9: 281-305.
- Young IS, Trouton TG, Torney JJ, et al. Genetic hemochromatosis and Wilson's Disease: role for oxidant stress? Free Radie Biol Med 1994; 16: 393-7.
- Stocker R. Lipoprotein oxidation: mechanistic aspects, methodological approaches and clinical relevance. Curr Opin Lipidol 1994; 5: 422-33.
- Ramm GA, Halliday JW, Fletcher LM, et al. Hepatic stellate cell activation in genetic hemochromatosis: lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 1997; 26: 584-92.
- Houglum K, Bedossa P, Chojkier M. TGF-B and collagen-al (I) gene expression are increased in hepatic acinar zone 1 of rats with iron overload. Am J Physiol 1994; 5: G908-13.
- Houglum K, Filip M, Witztum JL, Chojkier M. Malondialdehyde and 4-hydroxynoneal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 1990; 86: 1991-8.
- Houglum K, Lee KS, Chojkier M. Proliferation of hepatic stellate cells is inhibited by phosphorylation of CREB on serine 133. J Clin Invest 1997; 99: 1322-8.
- Houglum K, Ramm GA, Crawford DHG, et al. Excess iron induces hepatic transforming growth factor Betal in genetic hemochromatosis: role of oxidative stress. Hepatology 1997; 27: 605-10.
- Houglum K. Alcohol and iron: a radical combination? Hepatology 1996; 23: 1700-3.
- Jazwinska EC, Lee SC, Webb SI, et al. Localization of the hemochromatosis gene close to D65105. Am J Hum Genet 1993; 53: 347-52.
- Stone C, Pointon JJ, Jazwinska EC, et al. Isolation of CA dinucleotide repeats close to D65105; linkage disequilibrium with haemochromatosis. Hum MoI Genet 1994; 3: 2043-6.
- Worwood M, Raha-Chowdhury R, Dorak M, Darke C, Bowen D, Burnett A. Alleles at D6S265 and D6S105 define a haemochromato sis-specific genotype. Br J of Haematol 1994; 86: 863-6.
- Jazwinska EC, Pyper WR, Burt MJ, et al. Haplotype analysis in Australian hemochromatosis patients: evidence for a predominant ancestral haplotype exclusively associated with hemochromatosis. Am J Hum Genet 1995; 56: 428-33.
- Raha-Chowdhury R, Bowen DJ, Stone C, et al. New polymorphic microsatellite markers place the haemochromatosis gene telomeric to D6S105. Hum MoI Genet 1995; 4: 1869-74.
- Raha-Chowdhury R, Bowen D, Burnett A, Worwood M. Allelic associations and homozygosity in loci from HLA-B to D6S299 in genetic haemochromatosis. / Med Genet 1995; 32: 446-52.
- Malfroy L, Roth MP, Carrington M et al. Heterogeneity in rates of recombination in the 6-Mb region telomeric to the human major histocompatibility complex. Genomics 1997; 43: 226-31.
- Worwood M, Dorak MT, Nicklin S. The frequency of the haemochromatosis-associated genotype D6S265-1:D6S105-8 in blood donors. Br J Haematol 1996; 93: 838-40.
- Campbell RD, Trowsdale J. Map of the human MHC. lmmunol Today 1993; 14: 349-52.
- El Kalhoun A, Chauvel B, Mauvieux N, et al. Localization of seven new genes around the HLA-A locus. Hum MoI Genet 1993; 2: 55-60.
- Abderrahim H, Sambucy JL, Iris F, et al. Cloning the human major histocompatibility complex in YACs. Genomics 1994; 23: 520-7.
- Burt MJ, Smit DJ, Pyper WR, et al. A 4.5 megabase YAC contig and physical map over die hemochromatosis gene region. Genomics 1996; 33: 205-9.
- Totaro A, Rommens JM, Grifa A. Hereditary hemochromatosis: generation of a transcription map within a refined and extended map of the HLA class I region. Genomics 1996; 31: 319-26.
- Malaspina P, Roetto A, Trettel F, et al. Construction of a YAC contig covering human chromosome 6p22. Genomics 1996; 36: 399-407.
- Beutler E, Gelbart T, West C, et al. Mutation analysis in hereditary hemochromatosis. Blood Cells Molecules Dis 1996; 22: 187-94.
- Bodmer JG, Parham P, Ekkehard DA, Marsh SGE. Putting a hold on "HLA-H". Nat Genet 1997; 15: 234-5.
- Mercier B, Mura C, Ferec C. Putting a hold on "HLA-H". Nat Genet 1997; 15: 234-5.
- Beutler E. The significance of the 187G (H63D) mutation in hemochromatosis. [letter; comment]. Am J Hum Genet 1997; 61: 762-4.
- Beutler E. Genetic irony beyond haemochromatosis: clinical effect of HLA-H mutations. Lancet 1997; 349: 296-7.
- Martinez PA, Biron C, Blanc F, et al. Compound heterozygotes for hemochromatosis gene mutations: may they help to understand the pathophysiology of the disease? Blood CeIls Molecules Dis 1997; 23: 269-76.
- Risch R. Haemochromatosis, HFE and genetic complexity. Nat Genet 1997; 17: 375-6.
- Lebron JA, Bennett MJ, Vaughn DE, et al. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transform receptor. Cell 1998; 93: 111-23.
- Parkkila S, Waheed A, Britton RS, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastroentestinal tract. Proc Natl Acad Sci USA 1997; 94: 2534-9.
- Bjorkman PJ, Parham P. Structure, function and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 1990; 59: 253-88.
- Feder JN, Tsuchibashi Z, Irrinki A, et al. The hemochromatosis founder mutation in HLA-H disrupts beta-2-microglobulin interaction and cell surface expression. J Biol Chem 1997; 272: 14025-8.
- Waheed A, Parkkila S, Zhou XY, et al. Hereditary hemochromatosis: Effects of C282Y and H63D mutations on association with beta2microglobulin, intracellular processing and cell surface expression of the HFE protein in COS-7 cells. Proc Natl Acad Sci USA 1997; 94: 12384-9.
- Parkkila S, Waheed A, Britton RS, et al. Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis. Proc Natl Acad Sci USA 1997; 94: 13198-202.
- Andersen GJ, Powell LW, Halliday JW. Transferrin receptor distribution and regulation in the rat small intestine: effect of iron stores and erythropoiesis. Gastroenterology 1990; 98: 576-85.
- Banerjee D, Flanagan PR, Cluett J, Valberg LS. Transferrin receptors in the human gastrointestinal tract. Relationship to body iron stores. Gastroenterology 1986; 91: 861-9.
- De Sousa M, Reimao R, Lacerda P, et al. Iron overload in beta2microglobulin deficient mice. Immunol Lett 1994; 39: 105-11.
- Hashimoto K, Hirai M, Kurosawa Y. Identification of a mouse homolog for the human hereditary haemochromatosis candidate gene. Biochem Biophys Res Commun 1997; 230: 35-9.
- Zhou XY, Tomatsu S, Fleming RE, et al. HFE gene knockout produces mouse model of hereditary hemochromatosis. Proc Natl Acad Sci USA 1998; 95: 2492-7.
- Lebouef RC, Toison D, Heinecke JW. Dissociation between tissue iron concentrations and transferrin saturation among inbred mouse strains. / Lab Clin Med 1995; 126: 128-36.
- Yang B, Kirby S, Lewis J, et al. A mouse model for beta O-thalassemia. Proc Natl Acad Sci USA 1995; 92: 11608-12.
- Poss KD, Tonegawa S. Heme oxygenase 1 is required for mammalian iron reutilization. Proc Natl Acad Sci USA 1997; 94: 10919-24.
- Craven CM, Alexander J, Eldridge M, et at. Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse; a rodent model for hemochromatosis. Proc Natl Acad Sci USA 1987; 84: 3457-61.
- Guyader D, Jacquelinet C, Moirand R, et al. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastoenterology 1998; 115: 929-36.
- Adams PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clin Genet 1998; 53: 176-8.
- McLaren C, McLachlan G, Halliday J, et al. The distribution of transferrin saturation in an asymptomatic Australian population: relevance to the early diagnosis of hemochromatosis. Gastroenterology 1998; 114: 543-9.
- Burke W, Thomson E, Khoury MI, et al. Hereditary hemochromatosis: gene discovery and its implications for population-based screening. J Am Med Assoc 1998; 280: 172-8.
- Hickman P, Hourigan L, Powell LW, Crawford DHG. Automated measurement of unsaturated iron binding capacity allows a cost effective, ongoing strategy for screening for haemochromatosis. Hepatology 1998; 28: (4) 422A.
- Niederau C, Fisher R, Sonnenberg A, et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med 1985; 313: 125-62.
- Niederau C, Fischer R, Purschel A, et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-19.
- Baker ER, Monk CD, Do K, et al. The changing role of liver biopsy in hereditary haemochromatosis after the cloning of the HFE gene. Hepatology 1998; 28: 421A
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.